Health Enhancement Products, Inc. Finalizes Due Diligence With Zus Health, LLC
10. November 2010 13:56 ET
|
Health Enhancement Products, Inc
SCOTTSDALE, AZ--(Marketwire - November 10, 2010) - Health Enhancement Products, Inc., (OTCBB: HEPI) announced today that its due diligence period with Zus Health, LLC (Zus) has been completed and the...
Health Enhancement Products Appoints Dr. John D. Crissman to Its Board of Directors
19. Oktober 2010 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - October 19, 2010) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that Dr. John D. Crissman has been named to its Board of Directors.
John...
Health Enhancement Products, Inc. Announces the Issuance of a US Patent for Its Proprietary ProAlgaZyme(R) Algal Extract and the Treatment of Disease
13. Oktober 2010 14:27 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - October 13, 2010) - Health Enhancement Products, Inc. (OTCBB: HEPI) received notification of patent issuance regarding its proprietary algal extract...
Health Enhancement Products, Inc. Signs Distribution Agreement With LAVA Corporation of Seoul Korea
07. August 2008 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - August 7, 2008) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that they have signed a Memorandum of Understanding
(MOU) with Lava Corporation of...
Health Enhancement Products Signs Contract With Specialty Nutrition Group, Inc. for Re-Branding and Product Marketing of ProAlgaZyme
13. Dezember 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - December 13, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that they have entered into a re-branding and
marketing agreement with Specialty...
Health Enhancement Products Announced the Long Awaited Discovery of a Class of "Orally Active Agents" in Its Primary Product, ProAlgaZyme
14. November 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - November 14, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI),
announced today that the company has captured the active agents from it
primary product...
Health Enhancement Products Reports Results in the Second Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial
06. November 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - November 6, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that they have received the second, independent test
results of the clinical lot of...
Health Enhancement Products Reports Results in Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial
25. Oktober 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - October 25, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that they have received preliminary, independent
results of the clinical lot of...
Health Enhancement Products Announces the Signing of a Broker Agreement With Natural Brokers, Inc.
24. September 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - September 24, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) (the "Company") announced today that it had signed an agreement with
Natural Brokers, Inc., of...
Health Enhancement Products Announces Peer-Reviewed Publication of a Clinical Study Involving Metabolic Syndrome and Markers of Cardiovascular Health
10. September 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - September 10, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI), a Scottsdale, Arizona company, announced today the publication of a
peer-reviewed article...